Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT06860360
Eligibility Criteria:
Inclusion Criteria:
* Male or female participants aged ≥ 18 years
* Subjects must understand the requirements of the study and provide written informed consent.
MG
* Clinical signs or symptoms suggestive of MG and at least one of the following:
* A serologic test for AChR antibodies or MuSK antibodies or
* A diagnostic electrophysiological investigation supportive of the diagnosis MG or
* A positive neostigmine test Healthy control group
* Volunteers from spouses, friends and family accompanying patient or employees from our department
* No medical conditions affecting the facial muscles, e.g. Graves' disease, previous stroke with a facial palsy
* No use of medication affecting the facial features, e.g. prednisone
Exclusion Criteria:
* Inability to give written informed consent
* Inability to read Dutch/ English video-instructions
* Participants with active Graves' disease or unilateral facial paralysis
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06860360
Study Brief:
Protocol Section:
NCT06860360